← All companies

VNRX

VolitionRx Limited

VNRX NYSE In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$0.80

+0.08 +11.10%

Key statistics

from XBRL data in SEC filings

Market cap

$6.66M

Revenue (TTM)

$2.47M

Net income (TTM)

-$24.6M

EPS (TTM)

$-2.20

P/E ratio

—

Dividend yield

—

Free cash flow

-$19.8M

Cash

$3.10M

Total assets

$9.04M

Gross margin

—

52-week range

$0.69 – $15.20

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws; Shareholder vote results Jul 21, 2026 8-K Unregistered sale of equity Jun 18, 2026 8-K Entered a material agreement; Other events Jun 10, 2026 8-K Entered a material agreement May 22, 2026 8-K Director or officer change May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Modified rights of security holders; Amended charter or bylaws Apr 28, 2026 8-K Delisting notice or listing-rule failure; Other events Apr 23, 2026 8-K Other events Apr 17, 2026 8-K Shareholder vote results Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Unregistered sale of equity Feb 20, 2026 8-K Delisting notice or listing-rule failure; Other events Feb 9, 2026 8-K Entered a material agreement; Unregistered sale of equity Jan 8, 2026 8-K Director or officer change Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K/A Entered a material agreement Nov 13, 2025 8-K/A Entered a material agreement Nov 10, 2025 8-K Entered a material agreement Nov 7, 2025 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Oct 14, 2025 10-Q/A Quarter ended 2025-06-30 Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement; Other events Aug 4, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Entered a material agreement; Terminated a material agreement Apr 22, 2025 8-K Regulation FD disclosure Apr 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Entered a material agreement; Other events Mar 26, 2025 8-K Entered a material agreement; Other events Dec 9, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Director or officer change Nov 6, 2024